12 of 13
RAKHSHANI ET AL.
3.5 | Structure–Activity Relationship
The optimization of the molecular structures of L1, L2 and
Ni(II) and Cu(II) complexes of L2 was accomplished using
the DFT method (B3LYP) at 6‐31G* and LANL2DZ basis
set level. After that, DFT results for the frontier molecular
orbital energies were obtained. The frontier molecular
orbitals of these samples are shown in Figure 8.
REFERENCES
[1] D. G. Patil, M. R. Chedekel, J. Org. Chem. 1984, 49, 997.
[2] Z. F. Li, X. X. Cheng, G. Li, H. J. Lu, H. F. Zhang, J. Lumin.
2010, 130, 2192.
These results confirm the inverse connection between
the size of the band gap (ΔEL‐H) and the antibacterial
activities of these samples.[38,39,50–52] In other words, the
smaller is the difference between LUMO and HOMO
energies, the greater is the antibacterial activity. Accord-
ing to Figure 8, the Cu(L2)2 complex has the narrowest
band gap, which conforms to its greatest antibacterial
activity (Figures 6 and 7) among the investigated
compounds.
[3] N. Selvakumaran, N. S. Weng, E. R. T. Tiekink, R. Karvembu,
Inorg. Chim. Acta 2011, 376, 278.
[4] A. M. Mansour, Appl. Organometal. Chem. 2018, 32, e3928.
[5] W. Schiessl, R. Puchta, Ž. D. Bugarčić, F. W. Heinemann, R.
Eldik, Eur. J. Inorg. Chem. 2007, 1390.
[6] D. C. Schroeder, Chem. Rev. 1955, 55, 181.
[7] E. Rodrıǵ uez‐Fernández, E. Garcı́a, M. R. Hermosa, A.
Jiménez‐Sánchez, M. Mar Sánchez, E. Monte, J. J. Criado,
J. Inorg. Biochem. 1999, 75, 181.
[8] K. Chandrasekhara Pillai, R. Narayan, J. Electrochem. Soc. 1978,
125, 1393.
4 | CONCLUSIONS
[9] A. Mesbah, S. Jacques, E. Rocca, M. François, J. Steinmetz, Eur.
J. Inorg. Chem. 2011, 1315.
The intramolecular hydrogen bond in ligand L1 prevents
coordination of the carbonyl moiety to metal ions and
causes synthesis of a mixture of cis and trans complexes.
To eliminate this intramolecular hydrogen bond and favour
a bidentate chelating of ligand to metal ion, we prepared the
oxazolidine derivative of the L1 ligand, L2, and used it for
synthesis of the bis‐chelate Ni(II) and Cu(II) complexes.
The crystal structures of Ni(L2)2 and Cu(L2)2 revealed that
the Ni and Cu atoms display a nearly square planar geome-
try with two bidentate ligands having oxygen and sulfur as
donor atoms in cis position. In vitro antibacterial activity
experiments against E. coli and S. aureus showed that the
Cu(L2)2 complex has the strongest antibacterial activity
among the investigated compounds. This is due to the che-
lation of L2 to Cu2+ ion, which decreases its polarity and
increases the lipophilic property. Theoretical computations
illustrate that the antibacterial properties of the synthesized
compounds are related to the difference between frontier
orbital energies, where a decrease in the band gap energy
corresponds to an increase of the antibacterial activity.
[10] M. Ozcan, I. Dehri, M. Erbil, Appl. Surf. Sci. 2004, 236, 155.
[11] K. F. Khaled, Appl. Surf. Sci. 2010, 256, 6753.
[12] S. Saha, D. Dhanasekaran, S. Chandraleka, N. Thajuddin, A.
Panneerselvam, Adv. Biol. Res. 2010, 4, 224.
[13] H. M. Parekh, P. B. Pansuriya, M. N. Patel, Polish J. Chem. 2005,
79, 1843.
[14] V. Bobbarala, A Search for Antibacterial Agents, InTech, Rijeka,
Croatia 2012.
[15] B. H. Abdullah, Y. M. Salh, Orient. J. Chem. 2010, 26, 763.
[16] G. Kurt, F. Sevgi, B. Mercimek, Chem. Pap. 2009, 63, 548.
[17] K. R. Koch, Y. Wang, A. Coetzee, J. Chem. Soc. Dalton Trans.
1999, 63, 1013.
[18] E. D. Bergmann, Chem. Rev. 1953, 53, 309.
[19] M. Al‐Masum, B. W. Lott, N. Ghazialsharif, Int. J. Org. Chem.
2012, 362.
[20] E. D. Bergmann, E. Zimkin, S. Pinchas, Recl. Trav. Chim. Pays‐
Bas 1952, 71, 168.
[21] Crys AlisPro, Rigaku Oxford Diffraction, 2015.
[22] L. Palatinus, G. Chapuis, J. Appl. Crystallogr. 2007, 40, 786.
[23] V. Petricek, M. Dusek, L. Palatinus, Z. Kristallogr. 2014, 229, 345.
[24] J. Rohlicek, M. Husak, J. Appl. Crystallogr. 2007, 40, 600.
ACKNOWLEDGEMENTS
[25] N. Talebian, S. M. Amininezhad, M. Doudi, J. Photochem.
Photobiol. B 2013, 120, 66.
We thank USB for financial support. The crystallographic
investigation was supported by project 15‐12719S of the
Czech Science Foundation using instruments of the ASTRA
laboratory established within the Operation Program
Prague Competitiveness – project CZ.2.16/3.1.00/24510.
[26] S. M. Amininezhad, A. R. Rezvani, M. Amouheidari, S. M.
Amininejad, S. Rakhshani, J. Zahedan, Res. Med. Sci. 2015, 17,
e1053.
[27] H. Naeimi, Z. S. Nazifi, S. M. Amininezhad, J. Photochem.
Photobiol. B 2015, 149, 180.
[28] S. Bourne, K. R. Koch, J. Chem. Soc. Dalton Trans. 1993, 2071.
ORCID
[29] K. R. Koch, C. Sacht, S. Bourne, Inorg. Chim. Acta 1995,
232, 109.